The management of malignant biliary obstruction is a critical challenge in modern gastroenterology, where effective drainage is essential for palliation and prolongation of life. Traditionally, ...

IT IS frequently difficult to differentiate on-clinical grounds jaundice due to parenchymal liver disease and that secondary to extrahepatic biliary obstruction. This distinction is obviously ...

The procedure can be beneficial prior to chemotherapy, but it also has high rates of complications, this new analysis shows. People with unresectable perihilar cholangiocarcinoma (pCCA) can find ...

Medically reviewed by Jay N. Yepuri, MD Having ongoing pale poop can be due to conditions that affect the liver or bile duct.Treatment involves medications, surgeries, and lifestyle changes to restore ...

A bile duct drain, also called biliary drainage, can help treat blocked bile ducts so that bile may flow as it should, helping your liver digest fats. Learn more about biliary drainage, including how ...

Validation of the Spanish version of the QODD questionnaire (QODDq-ESP) in a home-based cancer palliative care program and development of the QODDq-ESP-12. This is an ASCO Meeting Abstract from the ...

PBC is a chronic liver disease that damages bile ducts and can lead to liver failure. You can get treatment for PBC to slow disease progression and manage symptoms like itching. There is no cure for ...

Zanidatamab-hrii received FDA accelerated approval for HER2-positive biliary tract cancer, showing a 52% objective response rate in the HERIZON-BTC-01 trial. Biliary tract cancers represent 3% of ...

The procedure of endoscopic removal of stone and blockage from the bile duct, followed by placement of Common Bile Duct (CBD) ...

Treatment with a glucagon-like peptide-1 (GLP-1) receptor agonist was associated with a 37% increase in the relative risk of gallbladder or biliary disease compared with controls — especially when ...

Ziihera is the first dual HER2-targeted bispecific antibody approved for HER2-positive BTC in the U.S., offering a chemotherapy-free treatment option. The FDA's accelerated approval was based on a 52% ...